Gerresheimer (GXI) investor relations material

Strategic vision and market positioning

• Focus on innovation and transformation into a global system and solution integrator for pharma, biotech, healthcare, and beauty industries.

• Leading partner status for global pharma, biotech, and healthcare, with a broad portfolio serving top industry players.

• Emphasis on sustainable growth, value creation, and long-term partnerships through high-volume manufacturing expertise.

• Strong foundation in containment and delivery solutions, bolstered by growth accelerators like digital solutions and high-value plastics.

• Over 150 years of progressive change, expanding from bottle making to diversified systems and solutions.

Product and solution portfolio

• Comprehensive offerings in glass and plastic containment, including vials, bottles, cartridges, ampoules, and closures.

• Advanced drug delivery systems such as autoinjectors, inhalers, pens, and on-body infusors, with proprietary IP solutions.

• Digital solutions for therapy support, traceability, and connected drug delivery systems.

• Specialized platforms for GLP-1 applications, including pen systems, cartridges, autoinjectors, and vials.

• High-performance products like Gx Inbeneo autoinjector and Gx InPuls on-body infusor, supporting self-administration and patient adherence.

Operational footprint and capacity expansion

• More than 40 production sites and 8 technical competence centers across 16 countries, serving over 90 countries.

• Ongoing capacity expansion projects in the USA, Mexico, Germany, North Macedonia, and China, with significant investments in device manufacturing.

• Peachtree City expansion to triple medical device output by 2028, creating over 400 new jobs.

• Querétaro site expansion for state-of-the-art syringe and EZ-fill Smart platform production.

• Annual production exceeds 25 billion products, including vials, ampoules, syringes, and plastic containers.